A Phase III Trial of Concurrent Radiation and Chemotherapy (Followed by Surgery for Residual Primary/N2-3 Nodal Disease) for Advanced Head and Neck Carcinomas
Principal Investigator
Phuc Felix Nguyen-Tan, MD
Status
Terminated
Date Opened To Accrual
July 30 2002
Date Closed to Accrual
June 23 2005
Date of Study Termination
May 20 2022
Disease Site
Head and Neck [HN]
Head and Neck
Phase
III
Developmental Therapeutics
No
Primary Objective
To determine whether intensification of radiation, relative to conventional fractionation plus cisplatin in the combined therapy setting can further improve the overall survival of patients with advanced HNSCC.
Data Collection Notice:
Data for this trial is being collected via the NRG/RTOG Data Center
Patient Population
Histologic proof of squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx
Target Accrual
720
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.